The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
复制标题
DOI:
10.1016/j.intimp.2020.107204
复制
发表时间:
2021-01
影响因子:
5.6
通讯作者:
Karampoor S
中科院分区:
文献类型:
--
作者:
Mirzaei R;Mahdavi F;Badrzadeh F;Hosseini-Fard SR;Heidary M;Jeda AS;Mohammadi T;Roshani M;Yousefimashouf R;Keyvani H;Darvishmotevalli M;Sani MZ;Karampoor S
The novel coronavirus disease 2019 (COVID-19) pandemic has imposed significant public health problems for the human populations worldwide after the 1918 influenza A virus (IVA) (H1N1) pandemic. Although numerous efforts have been made to unravel the mechanisms underlying the coronavirus, a notable gap remains in our perception of the COVID-19 pathogenesis. The innate and adaptive immune systems have a pivotal role in the fate of viral infections, such as COVID-19 pandemic. MicroRNAs (miRNAs) are known as short noncoding RNA molecules and appear as indispensable governors of almost any cellular means. Several lines of evidence demonstrate that miRNAs participate in essential mechanisms of cell biology, regulation of the immune system, and the onset and progression of numerous types of disorders. The immune responses to viral respiratory infections (VRIs), including influenza virus (IV), respiratory syncytial virus (RSV), and rhinovirus (RV), are correlated with the ectopic expression of miRNAs. Alterations of the miRNA expression in epithelial cells may contribute to the pathogenesis of chronic and acute airway infections. Hence, analyzing the role of these types of nucleotides in antiviral immune responses and the characterization of miRNA target genes might contribute to understanding the mechanisms of the interplay between the host and viruses, and in the future, potentially result in discovering therapeutic strategies for the prevention and treatment of acute COVID-19 infection. In this article, we present a general review of current studies concerning the function of miRNAs in different VRIs, particularly in coronavirus infection, and address all available therapeutic prospects to mitigate the burden of viral infections.
登录
查看更多内容
影响因子:
3.3
作者:
Dickey LL;Hanley TM;Huffaker TB;Ramstead AG;O'Connell RM;Lane TE
通讯作者:
Lane TE
DOI:
10.1099/vir.0.044255-0
发表时间:
2012-11
期刊:
The Journal of general virology
影响因子:
--
作者:
Bakre A;Mitchell P;Coleman JK;Jones LP;Saavedra G;Teng M;Tompkins SM;Tripp RA
通讯作者:
Tripp RA
影响因子:
3.5
作者:
Chow JT;Salmena L
通讯作者:
Salmena L
影响因子:
9.3
作者:
Dickey LL;Worne CL;Glover JL;Lane TE;O'Connell RM
通讯作者:
O'Connell RM
影响因子:
3.7
作者:
Allantaz F;Cheng DT;Bergauer T;Ravindran P;Rossier MF;Ebeling M;Badi L;Reis B;Bitter H;D'Asaro M;Chiappe A;Sridhar S;Pacheco GD;Burczynski ME;Hochstrasser D;Vonderscher J;Matthes T
通讯作者:
Matthes T